Dr. Dennis Slamon, Professor of Medicine, UCLA
Startups: TORL Biotherapeutics and 1200 Pharma
TORL is a unique company structure as UCLA is a founder of TORL. UCLA helps to fund the research that we are working on at TORL. The company determines new targets, validate targets to see if there can be new therapies to treat unmet medical needs including ovarian cancer and pancreatic cancer.
5 июн 2024
